Reuben Benjamin
- Oncology top 5%
- CAR-T cell therapy research 20
- Hematology top 5%
- Multiple Myeloma Research and Treatments 10
- Immunology top 10%
- Genetics top 10%
- Virus-based gene therapy research 8
- Chronic Lymphocytic Leukemia Research 5
- Genetics top 10%
- Virus-based gene therapy research 8
- Chronic Lymphocytic Leukemia Research 5
-
- Advancements in Semiconductor Devices and Circuit Design 5
-
- Viral Infectious Diseases and Gene Expression in Insects 4
- RNA Interference and Gene Delivery 4
- Protein Degradation and Inhibitors 4
- Co-authors
- Charlotte GrahamAgnieszka JóźwikStephen CobboldHerman WaldmannAndrea PepperMike ClarkMichel SadelainGertrude Gunset
- Cited by
- OncologyHematologyImmunology
- Journals
- Blood (7 papers)British Journal of Haematology (2 papers)The Journal of Gene Medicine (2 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Reuben Benjamin
41 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 78
- Oncology 498
- Hematology 168
- Immunology 295
- Genetics 107
- Genetics 252
Countries citing papers authored by Reuben Benjamin
This map shows the geographic impact of Reuben Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben Benjamin more than expected).
Fields of papers citing papers by Reuben Benjamin
This network shows the impact of papers produced by Reuben Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben Benjamin. The network helps show where Reuben Benjamin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Reuben Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 3 | |
| 12 | 2019 | 9 | |
| 13 | 2018 | 32 | |
| 14 | 2015 | 55 | |
| 15 | 2011 | 3 | |
| 16 | 2009 | 118 | |
| 17 | 2008 | 53 | |
| 18 | 2006 | 28 | |
| 19 | 1989 | 21 | |
| 20 | 1986 | 124 |
About Reuben Benjamin
Reuben Benjamin is a scholar working on Hematology, Oncology, Genetics, Immunology and Transplantation, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Multiple Myeloma Research and Treatments (10 papers), Virus-based gene therapy research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Advancements in Semiconductor Devices and Circuit Design (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), RNA Interference and Gene Delivery (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Oncology (498 citations), Hematology (168 citations), Immunology (295 citations), Genetics (107 citations) and Genetics (252 citations). Reuben Benjamin has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Charlotte Graham, Agnieszka Jóźwik, Stephen Cobbold, Herman Waldmann, Andrea Pepper, Mike Clark, Michel Sadelain, Gertrude Gunset, Maud Condomines and Kirsty Thomson. Their work appears in journals such as Blood, British Journal of Haematology, The Journal of Gene Medicine, HemaSphere and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.